Vermillion Soars on a Quiet Day: VRML $9 Up 23.2%
Vermillion (VRML) continues its wild ride upward from the November low of $4.53 on heavy volume of 546K shares with no apparent news. Two analysts cover the stock with a buy/outperform and Revenue Forecasts in the $7M range for Year Ending Dec.'11 and a Price Target of 10. The market cap is...
Rayno Snow Blog (La Nina Advisory) and Nat Gas Update (Bearish)
Yes there is snow everywhere in California and more to come. Mammoth has 161" month to date an all time record and 11-16 feet over past several days. Season TD snow is 255". Weather Geek : TahoeLoco.com Mammoth Lakes Weather brought to you by Howard Sheckter Natural Gas Update-Oversupply...
Another Good Day for Biotech Stocks:Incyte(INCY), Martek(MATK) and XBI
Clinical News and M&A Boost Biotechs Biotech stocks continued their seasonal strength with many winners in the mid-cap sector. Our index of 33 mid-cap stocks was up 2.7% which is unusually strong. Leaders were Incyte (INCY), Martek Biosciences (MATK) and the ETF XBI which owns a position in...
Weekly News Update: Dx Patents, XMRV, Avastin, Healthcare Reform
Significant Life Science News This Week Diagnostic Tests Can Be Patented, U.S. Court Rules - Bloomberg New Blood-Screening Advised - WSJ.com WABE: FDA Rules On Avastin Breast Cancer Drug (2010-12-17) Long legal fight ahead for health law - Politics - More politics - msnbc.com Health-Care Reform...
Biotech Rally Rolls On-Intermune (ITMN) Up 130%
Biotech Outperforms Large Cap Pharma Biotechnology stocks were up today sparked by Intermune (ITMN $32.74)news that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has adopted a positive opinion recommending their Esbriet (pirfenidone) drug for...